Skip to main content

ORIGINAL RESEARCH article

Front. Physiol., 28 June 2022
Sec. Metabolic Physiology
This article is part of the Research Topic Lipid Metabolism and human diseases View all 14 articles

RETRACTED: Abnormal Plasma Levels of Steroids and Their Ratios in Patients With Prurigo Nodularis: A Pilot Study

Retracted
Liuxi Chu,,&#x;Liuxi Chu1,2,3Xin Shu&#x;Xin Shu4Yan Wu,,Yan Wu1,2,3Haoran Yang,,Haoran Yang1,2,3Qin Lu,
Qin Lu1,5*Huihua Deng,,
Huihua Deng1,2,3*
  • 1School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China
  • 2Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing, China
  • 3Institute of Child Development and Education, Southeast University, Nanjing, China
  • 4Department of Dermatology, The Third Medical Centre of Chinese PLA General Hospital, Beijing, China
  • 5Department of Prescription Science, School of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China
This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Chu L, Shu X, Wu Y, Yang H, Lu Q and Deng H (2022) Abnormal Plasma Levels of Steroids and Their Ratios in Patients With Prurigo Nodularis: A Pilot Study. Front. Physiol. 13:835269. doi: 10.3389/fphys.2022.835269

Received: 14 December 2021; Accepted: 06 June 2022;
Published: 28 June 2022; Retracted: 19 September 2023.

Edited by:

Xian-Cheng Jiang, SUNY Downstate Medical Center, United States

Reviewed by:

Satoshi Iwase, Aichi Medical University, Japan
S’Hui Tian, Nanjing Medical University, China
Ying Xie, Huazhong University of Science and Technology, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.